Hatice Ilgen Sasmaz

Hatice Ilgen Sasmaz

Auto-generated profile, based on publicly available information

Hatice Ilgen Sasmaz

Cukurova Universitesi

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 December 2011 in Haemophilia
Verified
Journal Article
Closed access
PDF file
ISI. Sasmaz
I. Sasmaz
BAB. Antmen
B. Antmen
GLG. Leblebisatan
G. Leblebisatan
BKB. Şahin Karagün
B. Şahin Karagün
YKY. Kilinç
Y. Kilinç
RTR. Tuncer
R. Tuncer


18 August 2019 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
RERabia Miray Kisla Ekinci
Rabia Miray Kisla Ekinci
SBSibel Balcı
Sibel Balcı
ABAtıl Bışgın
Atıl Bışgın
ISIlgen Sasmaz
Ilgen Sasmaz
GLGoksel Leblebisatan
Goksel Leblebisatan
MYMustafa Yilmaz
Mustafa Yilmaz
Deficiency of Adenosine Deaminase 2 (DADA2) is a monogenic autoinflammatory disorder characterized by livedo reticularis, skin ulcers, subcutaneous rash, aphthous ulcers, and leukocytoclastic vasculitis, neurological signs such as early onset stroke and polyneuropathy. A minority of DADA2 patients suffer from severe cytopenia and lymphoproliferation. Herein, we report an adolescent patient, followed up as having a hematological disorder for many years, eventually diagnosed as having DADA2. In view of the presence of elevated acute phase reactants, hepatosplenomegaly, low IgM level, lymphopenia, anemia, and neutropenia, and a subtle neurological involvement we considered DADA2 diagnosis. The diagnosis was confirmed by identification of a novel L451W mutation in CECR1 gene. The patient has been successfully treated with etanercept, monthly intravenous immunoglobulin replacement, and low-dose methylprednisolone. In conclusion, although the absence of skin and neurological findings, low IgM levels, and persistent lymphopenia should lead the physicians to consider DADA2 in patients with particularly complicated hematological abnormalities.


31 March 2022 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
UAUtku Aygüneş
Utku Aygüneş
BKbarbaros sahin karagun
barbaros sahin karagun
HŞHatice İlGen Şaşmaz
Hatice İlGen Şaşmaz
TATuğana AKBAŞ
Tuğana AKBAŞ
AAAli Bulent Antmen
Ali Bulent Antmen
Purpose: The goal of this study is to explain the characteristics of COVID-19 in this demographic, as well as the impact it had on pediatric cancer care during the pandemic. Materials and Methods: Fifteen COVID-19 patients diagnosed were studied retrospectively. Clinical, laboratory and radiological data were collected in relation to 15 patients under the age of 18 who tested positive for Sars-CoV-2. Results: Of the 12117 pediatric hemato-oncological patients tested for COVID-19, 1125 patients showed symptoms, and 14 tested positive. The majority of cases suffered minor illnesses. A total of ten children required inpatient care, five needed oxygen support, and four required mechanical ventilation and later died. It was noted that the duration of real-time polymerase chain reaction (RT-PCR) positivity was prolonged in patients receiving intensive chemotherapy and/or immunosuppressive therapy. Patients’ chemotherapy was delayed in all 15 (100%) Sars-CoV-2-positive patients. Although changes visible on chest computed tomography (CT) imaging of children were mainly milder than in adults, radiological findings were more severe in patients who received relatively intensive cancer treatment. Conclusion: Children who have been treated for cancer or who have undergone a hematopoietic stem cell transplantation (HSCT) may be at greater risk of severe COVID-19 and should be under constant observation.